Valeant Pharmaceuticals International Inc said it planned to "improve" its $47 billion takeover offer for drugmaker Allergan Inc, a day after the U.S. company rejected the bid. Canada's Valeant said it remained committed to getting the deal done but would remain "financially disciplined."
Allergan, Inc. is a multi-specialty health care Company focused on developing and commercializing pharmaceuticals, biologics, medical devices and over-the-counter products. Shares of AGN fell by 0.98% or $-1.58/share to $159.72. In the past year, the shares have traded as low as $81.33 and as high as $170.05. On average, 4030000 shares of AGN exchange hands on a given day and today's volume is recorded at 6726057.
Valeant Pharmaceuticals International, Inc., formerly Biovail Corporation, is a multinational, specialty pharmaceutical company that develops, manufactures and markets a range of pharmaceutical products. Shares of VRX fell by 0.77% or $-1.01/share to $130.16. In the past year, the shares have traded as low as $73.25 and as high as $153.10. On average, 2719120 shares of VRX exchange hands on a given day and today's volume is recorded at 3864072.
Valeant Pharmaceuticals International, Inc., formerly Biovail Corporation, is a multinational, specialty pharmaceutical company that develops, manufactures and markets a range of pharmaceutical products. Shares of VRX fell by 0.69% or $-0.98/share to $141.98. In the past year, the shares have traded as low as $73.24 and as high as $170.45. On average, 386448 shares of VRX.TO exchange hands on a given day and today's volume is recorded at 282703.
Source
